Search results
Results from the WOW.Com Content Network
SentinelOne (NYSE: S) has investors curious about its potential as a long-term investment. * Stock prices used were the afternoon prices of Oct. 1, 2024. The video was published on Oct. 3, 2024.
The company's stock price is down. Here are factors to consider in buying the dip. Skip to main content. Sign in. Mail. 24/7 Help. For premium support please call: 800-290-4726 more ...
For now, SentinelOne has delivered a mixed stock performance. It has risen more than 60% since reaching its all-time low at the end of 2022. Still, it has gained little traction this year, and its ...
The combination milbemycin oxime/lufenuron (trade names Sentinel Flavor Tabs, by Novartis Animal Health, and Program plus) is a parasite control drug in which the active ingredient, milbemycin oxime, eliminates worms, while a second active ingredient, lufenuron, arrests the development of eggs and larvae, preventing them from maturing and continuing the infestation of an animal.
The stock price fell following a disappointing quarterly earnings report. Skip to main content. Sign in. Mail. 24/7 Help. For premium support please call: 800-290-4726 more ways to reach us ...
The stock continues to trade at a wide discount to peers on a price-to-sale (P/S) basis, despite similar revenue growth to CrowdStrike (29% last quarter) and much higher revenue growth than Palo ...
The AI-driven cybersecurity stock still trades far below its IPO price. Skip to main content. 24/7 Help. For premium support please call: 800-290-4726 more ways to reach us. Sign in. Mail. 24/7 ...
Image source: Getty Images. Valuation and verdict. From a valuation perspective, SentinelOne is the much cheaper stock, trading at less than half the forward price-to-sales (P/S) multiple of ...